Skip to main content
Clinical Trials/NCT04226144
NCT04226144TerminatedNot Applicable

Comparison Between Breath Stacking Technique Associated With Expiratory Muscle Training and Breath Stacking Technique in Amyotrophic Lateral Sclerosis Patients: a Randomized Single Blind Trial

Escola Superior de Ciencias da Saude1 site in 1 country50 target enrollmentStarted: January 6, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
maximal respiratory pressures

Study Overview

Brief Summary

it will be conducted a randomized parallel controlled trial with patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) to compare two techniques to lung recruitment and cough augmentation, to assess their effects on pulmonary function, global functionally, swallowing and ability to speech in these population.

Detailed Description

age over 18 years preserved cognition, evidenced by a score greater than or equal to 24 points in the Mini-Mental Status Exam; no barium allergies; without tracheostomy or invasive mechanical ventilation; no diaphragmatic pacemaker and without associated respiratory disease.Participants are excluded if they have pregnancy; previous kidney disease or other concomitant diseases; respiratory diseases and hospitalization in intensive care units (ICUs) during the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •diagnosis of neuromuscular disease confirmed by neurologists at the referral center for neuromuscular diseases at Brasília prior to screening for recruitment
  • •age over 18 years
  • •preserved cognition, evidenced by a score greater than or equal to 24 points in the Mini-Mental Status Exam;
  • •no barium allergies
  • •without tracheostomy or invasive mechanical ventilation
  • •no diaphragmatic pacemaker
  • •without associated respiratory disease

Exclusion Criteria

  • •pregnancy
  • •previous kidney disease or other concomitant diseases .respiratory diseases and hospitalization in intensive care units (ICUs) during the study.

Arms & Interventions

Breath Stacking Group

Active Comparator

The lungs are inflated as fully as possible by stacking successive breaths without expiration until the patients' maximal inspiratory capacity (MIC). The participant will be instructed to sustain the air in the lung, closing the glottis. Once the lungs are maximally inflated, the compressed air volume is released under expiratory muscle force, thus generating a cough with lung and chest wall recoil. They will perform 5-8 cycles of breath stacking per session, stacking 3-5 breaths per cycle.

Intervention: Breath Stacking Group (Device)

Breath stacking and EMT

Experimental

This group will perform the breath stacking technique in addiction with EMT. It will change the one-way valve in this group to VUP (Lumiar, Sao Paulo, Brazil) one-way valve, which allows the patients blow out the air with a counter resistance during all expiratory phase. The initial expiratory pressure will be 8 cmH2O, and could be changed at each visit according to participants' tolerance (either report easy or difficult to exhale assessed by research coordinators. The participants are encouraged to blow out the most slowly that they can do it.

Intervention: Breath stacking and EMT (Device)

Outcomes

Primary Outcomes

maximal respiratory pressures

Time Frame: from baseline to 24 weeks

change of decline rate of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) assessed by digital pressure (MVD-500 V.1.1 Microhard System,Porto Alegre, Brazil).

Peak cough flow

Time Frame: from baseline to 24 weeks

change of decline rate of peak cough flow (PCF) assessed by analogic peak cough flow meter (Respironics-Philips Health Care,PA,USA)

Forced Vital Capacity and Slow Vital Capacity

Time Frame: from baseline to 24 weeks

Change of decline rate of Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) predicted by brazilian population assessed by digital spirometer (Vitalgraph, London, UK)

Secondary Outcomes

  • swalloing function(from baseline to 24 weeks)
  • Voice parameters(from baseline to 24 weeks)
  • ALSFR-BR(from baseline to 24 weeks)

Investigators

Sponsor
Escola Superior de Ciencias da Saude
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vinicius Zacarias Maldaner da silva

PT, PhD

Escola Superior de Ciencias da Saude

Study Sites (1)

Loading locations...

Similar Trials